FCCC LOGO Faculty Publications
Movsas B , Teruya-Feldstein J , Smith J , Glatstein E , Epstein AH
Primary cardiac sarcoma - A novel treatment approach
Chest. 1998 Aug;114(2) :648-652
PMID: ISI:000075367700056   
Back to previous list
Primary cardiac sarcomas carry a dismal prognosis with no known curative therapy using standard treatment approaches. By its very location, the possibility of a radical complete resection- the underlying principle in the management of any soft-tissue sarcoma-is precluded. While literally in a continuous "blood bath," cardiac sarcomas are associated with a very high rate of hematogenous metastases. This report describes the management of a case in a 51-year-old white man with a high-grade unresectable cardiac sarcoma who was treated with hyperfractionated (twice daily) radiotherapy to a total dose of 7,050 eGy along with a radiosensitizer, (5'-iodode-oxyuridipne. The patient currently is disease-free and functioning well more than 5 years following this novel treatment approach.
Times Cited: 1 English Article 110ER CHEST